Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-16
2007-10-16
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S414000, C546S187000, C548S466000
Reexamination Certificate
active
11096664
ABSTRACT:
The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
REFERENCES:
patent: 4129655 (1978-12-01), Huebner et al.
patent: 5846982 (1998-12-01), Audia et al.
patent: 6673797 (2004-01-01), Hiroharu et al.
patent: 2311010 (1997-09-01), None
patent: WO94/20459 (1994-09-01), None
patent: WO9747302 (1997-12-01), None
patent: WO 01/21614 (2001-03-01), None
patent: WO 01/46179 (2001-06-01), None
patent: WO 01/58895 (2001-08-01), None
patent: WO01/85686 (2001-11-01), None
Basaria, S. et al.: Clinical Review 138: Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases; the J of Clin Endocrinology & Metabolism 86(11) pp. 5108-5117.
Chacun-Lefevre, L. et al.: Ring closure metathesis of indole 2-carboxylic acid allylamide derivatives; Tetrahedron 58 (2002) pp. 10181-10188.
Kuroita, T. et al.: “Preparation of cinnamamides and 3-phenylpropionamides as 5-HT1A receptor antagonists and their use as quick-acting antideparessants” (ABSTRACT).
Hesabi, M.M. et al.: “Light-induced reactions of heteroaryl N-methylanilinomethyl ketones: formation of 3-heteroaryl-1-phenylazetidin-3-ols” (ABSTRACT).
Morris, Jeffrey J, et al. “Non-Sterodial Antiandrogens. Design of Novel Compounds Based on an Infrared Study of the Dominant Conformation and Hydrogen-Bonding Properties of a Series of Anilide Antiandrogens”. Journal of Medicinal Chemistry, vol. 31, No. 1, 1991, pp. 447-455. XP002341814.
Netchitailo, P. et al.: Synthese de flavones et de xanthones dans la serie du benzo[4,5]thiophene; J. Heterocyclic Chem., 15, (1978) pp. 337-342.
Newling, D.W.W.: Anti-androgen in the treatment of prostate cancer; British J. of Urology (1996) 77, pp. 776-784.
Shahidi, N.T. MD.: a Review of the Chemistry, Bioilogical Action, and Clinical Applications of Anabolic-Androgenic Steroids; Clinical Therapeutics, vol. 23, No. 9. (2001) pp. 1355-1390.
Wells, G. et al.: 4-Substituted 4-Hydroxycyclohexa-2,5-dien-1-ones with Selective Activities against Colon and Renal Cancer Cell Lines; J. Med. Chem. (2003) 46, pp. 532-541.
PCT International Search Report, for International Appln. No. PCT/US2005/011106, dated Jul. 21, 2005.
Fiordeliso James J.
Jiang Weiqin
Lanter James C.
Sui Zhihua
Zhang Xuqing
Anderson Rebecca
Janssen Pharmaceutica N.V.
Nolan Jason M
LandOfFree
Indole derivatives as selective androgen receptor modulators... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives as selective androgen receptor modulators..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives as selective androgen receptor modulators... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3877204